Measuring Nausea, Vomiting, and Retching: The Modified Rhodes Index of Nausea and Vomiting Short Version for Research and Clinical Use

2.50
Hdl Handle:
http://hdl.handle.net/10755/165429
Category:
Abstract
Type:
Presentation
Title:
Measuring Nausea, Vomiting, and Retching: The Modified Rhodes Index of Nausea and Vomiting Short Version for Research and Clinical Use
Author(s):
Saltzman, E.; Shivnan, J. C.; Toman-Jager, A.; Mallik, R.; Melvin, M.; Roman, J.
Author Details:
E. Saltzman, Johns Hopkins Medical Center, Sidney Kimmel Comprehensive Cancer Center, School of Nursing, Baltimore, Maryland, USA; J. C. Shivnan; A. Toman-Jager; R. Mallik; M. Melvin; J. Roman
Abstract:
Nausea and vomiting (N/V) remain common and distressing side effects of preparative chemotherapy regimens for blood and marrow transplantation (BMT) and other intensive chemotherapy. Planning appropriate treatment interventions is dependent upon accurate assessment and documentation of patients’ perceptions of these symptoms. The purpose of this clinical project was to identify a valid, reliable, and clinically useful instrument to assess N/V and retching in BMT patients. We compared the validity of the 8-item Modified Rhodes Index of Nausea and Vomiting Scale (RINV) with our shortened version of the scale, the Modified Rhodes Index of N/V-Short Version (RINV-SV). The RINV provides information about nausea, vomiting, and retching, and patients’ perceived distress regarding these symptoms (Rhodes, Watson, & Johnson, 1983). It has been widely used in studies of cancer-related N/V and has been shown to have an internal reliability of .90 and .98, respectively, using a split half procedure and Cronbach’s Alpha (Rhodes, Watson, & Johnson, 1983; Rhodes, Watson & Johnson, 1987). The shortened version consists of 4 items taken from the original instrument and measures each of the sub-scales of N/V and retching. Content validity was confirmed by clinical experts. We compared the RINV with the RINV-SV as part of a randomized placebo-controlled clinical trial investigating the effectiveness of acupressure as adjunct to pharmacological control of emesis during the preparative regimen of BMT. Our instrument showed an internal consistency reliability of .92. The mean score of the RINV was 3.38 (range of 0-32), and the mean score of the RINV-SR was 1.83 (range of 0-16). The RINV-SV is reliable for BMT patients and has been incorporated into daily clinical assessment. In addition, the modified instrument is now the standard at our NCI-designated comprehensive cancer center and is used daily on each patient to assess and manage the symptoms of N/V and retching.
Repository Posting Date:
27-Oct-2011
Date of Publication:
27-Oct-2011
Conference Date:
2003
Conference Name:
28th Annual Oncology Nursing Society Congress
Conference Host:
Oncology Nursing Society
Conference Location:
Denver, Colorado, USA
Note:
This is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.

Full metadata record

DC FieldValue Language
dc.type.categoryAbstracten_US
dc.typePresentationen_GB
dc.titleMeasuring Nausea, Vomiting, and Retching: The Modified Rhodes Index of Nausea and Vomiting Short Version for Research and Clinical Useen_GB
dc.contributor.authorSaltzman, E.en_US
dc.contributor.authorShivnan, J. C.en_US
dc.contributor.authorToman-Jager, A.en_US
dc.contributor.authorMallik, R.en_US
dc.contributor.authorMelvin, M.en_US
dc.contributor.authorRoman, J.en_US
dc.author.detailsE. Saltzman, Johns Hopkins Medical Center, Sidney Kimmel Comprehensive Cancer Center, School of Nursing, Baltimore, Maryland, USA; J. C. Shivnan; A. Toman-Jager; R. Mallik; M. Melvin; J. Romanen_US
dc.identifier.urihttp://hdl.handle.net/10755/165429-
dc.description.abstractNausea and vomiting (N/V) remain common and distressing side effects of preparative chemotherapy regimens for blood and marrow transplantation (BMT) and other intensive chemotherapy. Planning appropriate treatment interventions is dependent upon accurate assessment and documentation of patients’ perceptions of these symptoms. The purpose of this clinical project was to identify a valid, reliable, and clinically useful instrument to assess N/V and retching in BMT patients. We compared the validity of the 8-item Modified Rhodes Index of Nausea and Vomiting Scale (RINV) with our shortened version of the scale, the Modified Rhodes Index of N/V-Short Version (RINV-SV). The RINV provides information about nausea, vomiting, and retching, and patients’ perceived distress regarding these symptoms (Rhodes, Watson, & Johnson, 1983). It has been widely used in studies of cancer-related N/V and has been shown to have an internal reliability of .90 and .98, respectively, using a split half procedure and Cronbach’s Alpha (Rhodes, Watson, & Johnson, 1983; Rhodes, Watson & Johnson, 1987). The shortened version consists of 4 items taken from the original instrument and measures each of the sub-scales of N/V and retching. Content validity was confirmed by clinical experts. We compared the RINV with the RINV-SV as part of a randomized placebo-controlled clinical trial investigating the effectiveness of acupressure as adjunct to pharmacological control of emesis during the preparative regimen of BMT. Our instrument showed an internal consistency reliability of .92. The mean score of the RINV was 3.38 (range of 0-32), and the mean score of the RINV-SR was 1.83 (range of 0-16). The RINV-SV is reliable for BMT patients and has been incorporated into daily clinical assessment. In addition, the modified instrument is now the standard at our NCI-designated comprehensive cancer center and is used daily on each patient to assess and manage the symptoms of N/V and retching.en_GB
dc.date.available2011-10-27T12:18:23Z-
dc.date.issued2011-10-27en_GB
dc.date.accessioned2011-10-27T12:18:23Z-
dc.conference.date2003en_US
dc.conference.name28th Annual Oncology Nursing Society Congressen_US
dc.conference.hostOncology Nursing Societyen_US
dc.conference.locationDenver, Colorado, USAen_US
dc.description.noteThis is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.-
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.